Incidence characteristics of five major malignant tumors in Nanning City
ZHAO Lin1, JIANG Longyan1, XU Bin2, TANG Xianyan1
1. School of Public Health, Guangxi Medical University, Nanning, Guangxi 530021, China; 2. Nanning Center for Disease Control and Prevention, Nanning, Guangxi 530023, China
Abstract：Objective To investigate the incidence and trends of liver, lung, breast, colorectal and gastric cancers in Nanning City from 2018 to 2022. Methods Data of new cases of liver, lung, breast, colorectal and gastric cancers in Nanning City from 2018 to 2022 were collected through the big data platform of the Nanning Health Propaganda and Information Center's Hospitalization System. The incidence rates were calculated and standardized using the data of the seventh national population census in 2020. The age, gender, and urban-rural distribution of the five malignant tumor cases were descriptively analyzed. The trends in incidence of the five malignant tumors were analyzed using annual percent change (APC). Results From 2018 to 2022, the crude and standardized incidence rates of liver cancer in Nanning City were 24.46/105 and 26.39/105, respectively, showing upward trends (APC=15.122% and 13.111%, both P<0.05). The crude and standardized incidence rates of lung cancer were 23.42/105 and 25.83/105, respectively, showing upward trends (APC=13.714% and 10.056%, both P<0.05). The crude and standardized incidence rates of breast cancer were 19.13/105 and 20.29/105, respectively, with no significant trends (APC=-5.129% and -5.164%, both P>0.05). The crude incidence rate of colorectal cancer was 18.81/105, showing an upward trend (APC=8.164%, P<0.05), while the standardized incidence rate was 20.64/105, with no significant trend (APC=5.044%, P>0.05). The crude incidence rate of gastric cancer was 7.27/105, showing an upward trend (APC=5.984%, P<0.05), while the standardized incidence rate was 7.98/105, with no significant trend (APC=3.304%, P>0.05). The age of onset peak for liver cancer was 65 to <70 years, for lung cancer was 75 to <80 years, for breast cancer was 55 to <60 years, for colorectal cancer was 80 to <85 years, and for gastric cancer was 75 to <80 years. The standardized incidence rates of liver, lung, colorectal and gastric cancers were higher in males than in females (all P<0.05). The standardized incidence rates of liver, lung and gastric cancers were higher in rural areas than in urban areas, while the standardized incidence rates of breast and colorectal cancers were lower in rural areas (all P<0.05). Conclusions The incidence rates of liver, lung, colorectal and gastric cancers in Nanning City showed upward trends from 2018 to 2022, while the incidence rate of breast cancer remained stable. The standardized incidence rates of liver, lung, colorectal and gastric cancers were higher in males, and the standardized incidences of liver, lung and gastric cancers were higher in rural areas.
[1] BRAY F,LAVERSANNE M,SUNG H,et al.Global cancer statistics 2022:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2024,74(3):229-263. [2] HAN B F,ZHENG R S,ZENG H M,et al.Cancer incidence and mortality in China,2022[J].J Natl Cancer Cent,2024,4(1):47-53. [3] 周子寒,李秋林,余家华,等.2019年广西恶性肿瘤流行情况及疾病负担分析[J].中国癌症防治杂志,2024,16(1):66-75. ZHOU Z H,LI Q L,YU J H,et al.Analysis of the epidemiological characteristics and disease burden of malignant tumors in Guangxi,2019[J].Chin J Oncol Prev Treat,2024,16(1):66-75.(in Chinese) [4] 黄秋兰,叶琳,周吉,等.2017年南宁市肿瘤登记地区主要恶性肿瘤发病和死亡分析[J].中国肿瘤,2022,31(3):187-196. HUANG Q L,YE L,ZHOU J,et al.Incidence and mortality of malignant tumors in cancer registration areas of Nanning City,2017[J].China Cancer,2022,31(3):187-196.(in Chinese) [5] WANG B H,HE F D,HU Y N,et al.Cancer incidence and mortality and risk factors in member countries of the "Belt and Road" initiative[J/OL].BMC Cancer,2022,22(1)[2024-11-04].https://doi.org/10.1186/s12885-022-09657-3. [6] 李秋林,曹骥,容敏华,等.2010—2016年广西肿瘤登记地区肝癌发病和死亡分析及变化趋势[J].中国癌症防治杂志,2021,13(2):138-143. LI Q L,CAO J,RONG M H,et al.Analysis of incidence and mortality of liver cancer in cancer registration areas in Guangxi,2010–2016[J].Chin J Oncol Prev Treat,2021,13(2):138-143.(in Chinese) [7] 何凤蝶,王秋童,胡亚男,等.中国人群肝癌发病危险因素病例对照研究的meta分析[J].现代预防医学,2022,49(23):4230-4240. HE F D,WANG Q T,HU Y N,et al.Meta-analysis of case-control studies on risk factors for liver cancer in the Chinese population[J].Mod Prev Med,2022,49(23):4230-4240.(in Chinese) [8] 曹骥,葛莲英,余家华,等.广西肿瘤防控工作发展历程和展望[J].中国癌症防治杂志,2019,11(4):271-275. CAO J,GE L Y,YU J H,et al.Development and prospect of Guangxi cancer prevention and control work[J].Chin J Oncol Prev Treat,2019,11(4):271-275.(in Chinese) [9] CHEN K,SHEN Z W,GU W J,et al.Prevalence of obesity and associated complications in China:a cross-sectional,real-world study in 15.8 million adults[J].Diabetes Obes Metab,2023,25(11):3390-3399. [10] 肖文博,朱广涵,朱云,等.1990—2019年中国主要消化系统恶性肿瘤发病变化分析[J].中国肿瘤,2022,31(9):693-700. XIAO W B,ZHU G H,ZHU Y,et al.Incidence of major digestive system cancers in China,1990-2019[J].China Cancer,2022,31(9):693-700.(in Chinese) [11] 赫捷,陈万青,李兆申,等.中国胃癌筛查与早诊早治指南(2022,北京)[J].中国肿瘤,2022,31(7):488-527. HE J,CHEN W Q,LI Z S,et al.China guideline for the screening,early detection and early treatment of gastric cancer(2022,Beijing)[J].China Cancer,2022,31(7):488-527.(in Chinese) [12] 邵云兰,刘杰,张香悠,等.江西省信州区居民2011—2020年恶性肿瘤发病状况分析[J].安徽预防医学杂志,2024,30(2):160-164. SHAO Y L,LIU J,ZHANG X Y,et al.Analysis of the prevalence of malignant tumors among residents in Xinzhou District Jiangxi Province from 2011 to 2020[J].Anhui J Prev Med,2024,30(2):160-164.(in Chinese) [13] 赵芳芳,林君英,王冬飞,等.萧山区恶性肿瘤死亡趋势分析[J].预防医学,2024,36(1):78-81. ZHAO F F,LIN J Y,WANG D F,et al.Trend in mortality of malignant tumors in Xiaoshan District[J].China Prev Med J,2024,36(1):78-81.(in Chinese) [14] 曹明丽,王淼,刘亚,等.2008—2016年天津市河西区肝癌发病与死亡趋势分析[J].中华肿瘤防治杂志,2021,28(8):562-566. CAO M L,WANG M,LIU Y,et al.Analysis of incidence and mortality trend of liver cancer in Hexi District of Tianjin from 2008 to 2016[J].Chin J Cancer Prev Treat,2021,28(8):562-566.(in Chinese) [15] 刘茵,陈琼,郭兰伟,等.2017年河南省肺癌流行现状及2010—2017年趋势分析[J].中国肿瘤,2022,31(2):112-118. LIU Y,CHEN Q,GUO L W,et al.Incidence and mortality of lung cancer in Henan Province in 2017 and trend from 2010 to 2017[J].China Cancer,2022,31(2):112-118.(in Chinese) [16] RAMADAN M,ALSIARY R A,ABOALOLA D A.Mortality-to-incidence ratio of early-onset colorectal cancer in high-income Asian and Middle Eastern countries:a systemic analysis of the Global Burden of Diseases Study 2019[J].Cancer Med,2023,12(21):20604-20616.
